… of the risk of cancers associated with immunosuppressive drug regimens in transplant … less
potently immunosuppressive drug regimens suggest that an increased risk of cancers is also …

… recipients have an increased incidence of cancer; one study found that after 20 years of
immunosuppressive therapy, 40 percent of recipients had cancer. Further burdens are to be …

… treatment with immunosuppressive drugs and the excess of skin cancer was confined to …
in the doses of immunosuppressive drugs given to the patients who developed cancer and the …

… evaluating overall and cancer mortality in relation to immunosuppressive drug exposure
among … Overall and cancer mortality in relation to use or non-use of immunosuppressive drugs …

… What is the effect of these agents on existing cancers? … –6% incidence of de novo cancers
in organ homograft recipients treated with chronic immunosuppressive therapy. These findings …

… Selective inhibitors of kinases and phosphatases are being developed as anti-cancer
drugs, and their immunosuppressive and anti-inflammatory activities are being investigated in …

… drug (nucleoside analogue), used for the treatment of pancreatic, breast, ovarian, and lung
cancers, has … We have recently demonstrated in different mouse cancer models that this drug …

… non-transplant patients who received each of these drugs or, with the exception of non-Hodgkin's
lymphoma and bladder cancer, the number of cases of cancer in each drug-use group. …

… Additionally, some immunosuppressive drugs can directly promote cancer … immunosuppressive
drugs can cause mutations in deoxyribonucleic acid (DNA), which can lead to cancer…

… The absence of cases of non-Hodgkin’s lymphoma among the subgroup of 214 patients
treated with immunosuppressive drugs in this study has such wide confidence limits that the …